Bringing What We Learned at the Virtual CHEST Conference Into Practice

Listen to experts report on current publications, posters, and sessions from a recent pulmonology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

HRCT in Fibrotic Interstitial Lung Disease

Launched: October 28, 2020

Updates on Diffuse Lung Disease

Launched: October 28, 2020

Controversies in the Use of Transbronchial Cryrobiopsy in the Diagnosis of Diffuse Lung Disease: A Pro Con Debate

Launched: October 28, 2020

Characteristics of Patients In the IPF-PRO Registry
 

Launched: October 28, 2020

Outcomes In Patients With Idiopathic Pulmonary Fibrosis And Pulmonary Hypertension

Launched: October 28, 2020

The Cost Associated with Antifibrotic-Treated Vs Untreated Patients with IPF in the Medicare Population

Launched: October 28, 2020

Surgical Lung Biopsy in the Management of Hospitalized Patients with Suspected ILD

Launched: October 28, 2020

Comorbidities in Interstitial Lung Diseases- An Overlooked Burden

Launched: October 28, 2020

When Is it PF-ILD? Diagnosis, Monitoring, and Treatment of a Complex Disease

Launched: October 28, 2020

Effect of Nintedanib in Patients With PF-ILDs: Further Analyses of the INBUILD Trial

Launched: October 28, 2020

Impact of Patient Education and Follow-Up With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Launched: October 28, 2020